N

NuCana plc
D

NCNA

1.26000
USD
0.02
(1.61%)
Market Closed
Volume
2,284
EPS
-14
Div Yield
-
P/E
-0
Market Cap
2,830,464
OverviewSignalsIdeasNews
Related Instruments
    A
    ALT
    -0.85500
    (-10.11%)
    7.60000 USD
    A
    AQST
    -0.13000
    (-2.84%)
    4.44500 USD
    B
    BNTX
    -3.740
    (-3.61%)
    99.740 USD
    C
    CODX
    -0.04000
    (-3.64%)
    1.06000 USD
    E
    EBS
    -1.55000
    (-16.74%)
    7.71000 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    N
    NVAX
    0.12000
    (1.67%)
    7.32500 USD
    T
    TBIO
    0
    (0%)
    0.000000 USD
    V
    VXRT
    -0.05030
    (-7.97%)
    0.58050 USD
    More
News

Title: NuCana plc

Sector: Healthcare
Industry: Biotechnology
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.